ArticleAmerican journal of translational research2021

Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma.

Ying-Ying Ge et al.PubMed ↗Full text ↗

No numbers read from the abstract.